Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Sarcoma × Octreotide × Clear all

Sponsor

Conditions

Neuroendocrine Tumors 6 Neoplasms 4 Carcinoid Tumor 4 Carcinoma 3 Vipoma 2 Neoplasm Metastasis 2 Intestinal Obstruction 2 Carcinoma, Islet Cell 2 Somatostatinoma 1 Recurrence 1 Prostatic Neoplasms 1 Primary Inoperable Thymoma 1 Pleural Effusion 1 Peritoneal Neoplasms 1 Malignant Carcinoid Syndrome 1 Lymphangiomyoma 1 Lymphangioleiomyomatosis 1 Insulinoma 1 Glucagonoma 1 Gastro-enteropancreatic neuroendocrine tumor 1 Gastrinoma 1 Diarrhea 1 Chylous Ascites 1 Chylothorax 1 Carcinoma, Neuroendocrine 1 Breast Neoplasms 1 Ascites 1 Adenoma, Islet Cell 1

Interventions

Doxorubicin 31 Ifosfamide 22 pazopanib 17 Gemcitabine 15 Cyclophosphamide 14 Radiotherapy 13 pembrolizumab 11 Filgrastim 10 Docetaxel 10 Vincristine 9 Sirolimus 9 Etoposide 9 Irinotecan 8 Bevacizumab 8 Sorafenib 7 temsirolimus 6 olaratumab 6 eribulin 6 Mesna 6 cixutumumab 5 Trabectedin 5 Radiosurgery 5 Radiation 5 Magnetic Resonance Spectroscopy 5 Granulocyte Colony-Stimulating Factor 5 tazemetostat 4 etoposide phosphate 4 Temozolomide 4 Nivolumab 4 Ipilimumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡